SNCA and Parkinson disease: siRNAs-RVG-exosomes have been delivered for an effective knockdown of expression for both the Aβ and tau peptides of Alzheimer’s disease and the alpha-synuclein of Parkinson’s disease as a long-term treatment for these neurodegenerative diseases [166].